BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1217975)

  • 1. [Neuropsychological investigations on short-time effects of biperiden (Akineton) in Parkinson's Disease (author's transl)].
    Schneider E; Jacobi P; Maxion H; Fischer P-A
    Arch Psychiatr Nervenkr (1970); 1975 Dec; 221(1):15-28. PubMed ID: 1217975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-dopa, biperiden and sebum excretion in Parkinson disease].
    Villares JC
    Arq Neuropsiquiatr; 1989 Mar; 47(1):31-8. PubMed ID: 2764750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute schizophrenic stupor: the effect of biperiden (author's transl)].
    Winter E; Grosse R
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):383-7. PubMed ID: 504345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of biperiden in delayed-release form in the treatment of Parkinson's disease and parkinsonian syndromes of various etiologies. Clinical experiments].
    Puntoni U
    Clin Ter; 1983 Oct; 107(1):37-44. PubMed ID: 6653070
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of MIF (melanocyte-stimulating hormone-release inhibiting factor) on psychomotor function and mood in parkinsonian patients. Preliminary report (author's transl)].
    Schneider E; Fischer PA; Jacobi P; Reh W
    Arzneimittelforschung; 1978; 28(8):1296-7. PubMed ID: 37848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the neuroleptic syndrome by biperiden hydrochloride under its delayed-action form. A 9-month study on 55 hospitalized patients].
    Verdeau-Pailles J
    Encephale; 1976; 2(4):341-7. PubMed ID: 1001242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of biperiden hydrochloride (Akineton) and benzhexol (Artane) in the treatment of drug-induced Parkinsonism.
    Magnus RV
    J Int Med Res; 1980; 8(5):343-6. PubMed ID: 7418951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous injection of biperiden and clonazepam in dystonia.
    Povlsen UJ; Pakkenberg H
    Mov Disord; 1990; 5(1):27-31. PubMed ID: 2296254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of biperiden on nap sleep after sleep deprivation in depressed patients.
    Dressing H; Riemann D; Gann H; Berger M
    Neuropsychopharmacology; 1992 Aug; 7(1):1-5. PubMed ID: 1524654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)].
    Gründig E; Gerstenbrand F
    Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
    Agid Y; Quinn N; Lhermitte F
    Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
    Jellinek T
    Dis Nerv Syst; 1977 May; 38(5):353-5. PubMed ID: 852367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Akineton in attacks of pain].
    Heinrich K
    Dtsch Med Wochenschr; 1977 Dec; 102(50):1865. PubMed ID: 590124
    [No Abstract]   [Full Text] [Related]  

  • 15. No antidepressant effect of biperiden compared with placebo in depression: a double-blind 6-week clinical trial.
    Gillin JC; Lauriello J; Kelsoe JR; Rapaport M; Golshan S; Kenny WM; Sutton L
    Psychiatry Res; 1995 Sep; 58(2):99-105. PubMed ID: 8570773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment.
    Gerlach J; Thorsen K
    Int Pharmacopsychiatry; 1976; 11(1):1-7. PubMed ID: 770362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].
    Fischer PA; Jacobi P; Schneider E; Schönberger B
    Arzneimittelforschung; 1977 Jul; 27(7):1487-9. PubMed ID: 332193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticholinergic biperiden in depressive disorders.
    Kasper S; Moises HW; Beckmann H
    Pharmacopsychiatria; 1981 Nov; 14(6):195-8. PubMed ID: 7323139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of biperiden in Parkinson's disease.
    Strang RR
    Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.